Checklist for reporting a prediction model development/validation

Describe the study design or source of data (e.g., randomized trial, cohort, or registry data), separately for the development and validation data sets, if applicable.

Specify the key study dates, including start of accrual; end of accrual; and, if applicable, end of follow-up.

Specify key elements of the study setting (e.g., primary care, secondary care, general population) including number and location of centres.

Describe eligibility criteria for participants.

Give details of treatments received, if relevant.

Clearly define the outcome that is predicted by the prediction model, including how and when assessed.

Report any actions to blind assessment of the outcome to be predicted.

Clearly define all predictors used in developing or validating the multivariable prediction model, including how and when they were measured.

Report any actions to blind assessment of predictors for the outcome and other predictors.

Explain how the study size was arrived at.

Describe how missing data were handled (e.g., complete-case analysis, single imputation, multiple imputation) with details of any imputation method.

If you are developing a prediction model describe how predictors were handled in the analyses.

If you are developing a prediction model, specify type of model, all model-building procedures (including any predictor selection), and method for internal validation.

If you are validating a prediction model, describe how the predictions were calculated.

Specify all measures used to assess model performance and, if relevant, to compare multiple models.

If you are validating a prediction model, describe any model updating (e.g., recalibration) arising from the validation, if done.

Provide details on how risk groups were created, if done.

For validation, identify any differences from the development data in setting, eligibility criteria, outcome, and predictors.

Describe the flow of participants through the study, including the number of participants with and without the outcome and, if applicable, a summary of the follow-up time. A diagram may be helpful.

Describe the characteristics of the participants (basic demographics, clinical features, available predictors), including the number of participants with missing data for predictors and outcome.

For validation, show a comparison with the development data of the distribution of important variables (demographics, predictors and outcome).

If developing a model, specify the number of participants and outcome events in each analysis.

If developing a model, report the unadjusted association, if calculated between each candidate predictor and outcome.

If developing a model, present the full prediction model to allow predictions for individuals (i.e., all regression coefficients, and model intercept or baseline survival at a given time point).

If developing a prediction model, explain how to the use it.

Report performance measures (with CIs) for the prediction model.

If validating a model, report the results from any model updating, if done (i.e., model specification, model performance).

Discuss any limitations of the study (such as nonrepresentative sample, few events per predictor, missing data).

For validation, discuss the results with reference to performance in the development data, and any other validation data.

Give an overall interpretation of the results, considering objectives, limitations, results from similar studies, and other relevant evidence.

Discuss the potential clinical use of the model and implications for future research.

Provide information about the availability of supplementary resources, such as study protocol, Web calculator, and data sets.

Give the source of funding and the role of the funders for the present study.